Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
superbug
Biotech
Affinivax banks $120M for vaccines against hospital superbugs
Affinivax reeled in $120 million to advance is pipeline, including vaccines against hospital-associated infections like E. coli and C. diff.
Amirah Al Idrus
Apr 23, 2020 7:00am
Qiagen launches one-stop antimicrobial resistance database
Jun 18, 2019 11:17am
Novo Holdings ponies up $165M for superbug venture fund
Feb 28, 2018 10:25am
J&J neurovascular biz; Olympus fined over outbreak—News of Note
Jul 26, 2017 11:18am
